# HilleVax, Inc.

HilleVax, Inc. is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** HilleVax, Inc.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Boston, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001888012

## About

HilleVax, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001888012, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-03-28, it reported net income of USD -147,267,000; total assets of USD 192,690,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$147.3M (USD -147,267,000)
- **Total assets:** $192.7M (USD 192,690,000)
- **Cash and equivalents:** $154.5M (USD 154,467,000)
- **Operating cash flow:** -$108.8M (USD -108,791,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$123.6M (USD -123,566,000)
- **Total assets:** $344.4M (USD 344,434,000)
- **Cash and equivalents:** $216.7M (USD 216,678,000)
- **Operating cash flow:** -$86.8M (USD -86,783,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$159.8M (USD -159,809,000)
- **Total assets:** $317.2M (USD 317,211,000)
- **Cash and equivalents:** $279.4M (USD 279,401,000)
- **Operating cash flow:** -$62.0M (USD -61,989,000)

## Recent SEC filings

- Form 8-K — filed 2025-09-17 — period 2025-09-17 — 8-K
- Form 10-Q — filed 2025-08-06 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-06 — period 2025-08-06 — 8-K
- Form 8-K — filed 2025-08-04 — period 2025-07-31 — 8-K
- Form 8-K — filed 2025-06-25 — period 2025-06-23 — 8-K
- Form 10-Q — filed 2025-05-08 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-08 — period 2025-05-08 — 8-K
- Form DEF 14A — filed 2025-04-30 — period 2025-06-23 — DEF 14A
- Form 10-K — filed 2025-03-28 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-28 — period 2025-03-28 — 8-K
- Form 8-K — filed 2024-12-05 — period 2024-12-04 — 8-K
- Form 10-Q — filed 2024-11-07 — period 2024-09-30 — 10-Q

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/hillevax-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology